Amalia Gastaldelli
Impact in
- Endocrinology, Diabetes and Metabolism top 0.02%
- Diet, Metabolism, and Disease
- Diabetes Treatment and Management
- Epidemiology top 0.05%
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 118
- Liver Disease Diagnosis and Treatment 101
-
- Diet, Metabolism, and Disease 37
- Diabetes Treatment and Management 33
- Co-authors
- Ele Ferrannini (65 shared papers)Ralph A. DeFronzo (36 shared papers)Melania Gaggini (56 shared papers)Kenneth Cusi (17 shared papers)Andrea Mari (37 shared papers)Elisabetta Bugianesi (31 shared papers)Robert R. Wolfe (13 shared papers)Labros S. Sidossis (10 shared papers)
- Journals
- Diabetes (27 papers)The Journal of Clinical Endocrinology & Metabolism (23 papers)Diabetologia (20 papers)Journal of Hepatology (16 papers)American Journal of Physiology-Endocrinology and Metabolism (16 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Amalia Gastaldelli
350 papers receiving 26.4k citations
Amalia Gastaldelli's Hit Papers
Peers
Comparison fields: 5 of 169
- Endocrinology, Diabetes and Metabolism 8.3k
- Epidemiology 9.6k
- Physiology 5.9k
- Hepatology 1.4k
- Cell Biology 2.4k
Countries citing papers authored by Amalia Gastaldelli
This map shows the geographic impact of Amalia Gastaldelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amalia Gastaldelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amalia Gastaldelli more than expected).
Fields of papers citing papers by Amalia Gastaldelli
This network shows the impact of papers produced by Amalia Gastaldelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amalia Gastaldelli. The network helps show where Amalia Gastaldelli may publish in the future.
Co-authors
The 25 scholars most cited alongside Amalia Gastaldelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 359 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis Hit paper breakdown → | 2006 | 1469 |
| 2 | Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration Hit paper breakdown → | 1993 | 1382 |
| 3 | EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) Hit paper breakdown → | 2024 | 758 |
| 4 | Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease Hit paper breakdown → | 2013 | 666 |
| 5 | Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms Hit paper breakdown → | 2005 | 617 |
| 6 | Why does obesity cause diabetes? Hit paper breakdown → | 2022 | 570 |
| 7 | Relationship Between Hepatic/Visceral Fat and Hepatic Insulin Resistance in Nondiabetic and Type 2 Diabetic Subjects Hit paper breakdown → | 2007 | 504 |
| 8 | 2005 | 442 | |
| 9 | The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis Hit paper breakdown → | 2015 | 422 |
| 10 | 2003 | 411 | |
| 11 | 2008 | 367 | |
| 12 | 2011 | 366 | |
| 13 | Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial Hit paper breakdown → | 2022 | 356 |
| 14 | 2005 | 350 | |
| 15 | 2011 | 347 | |
| 16 | Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance Hit paper breakdown → | 2017 | 343 |
| 17 | 2007 | 337 | |
| 18 | From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options Hit paper breakdown → | 2019 | 327 |
| 19 | 2009 | 320 | |
| 20 | Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests Hit paper breakdown → | 2021 | 308 |
About Amalia Gastaldelli
Amalia Gastaldelli is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism, Physiology, Surgery and Molecular Biology, having authored 359 papers that have together received 27.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (101 papers), Adipose Tissue and Metabolism (39 papers), Diet, Metabolism, and Disease (37 papers), Diet and metabolism studies (37 papers), Metabolism, Diabetes, and Cancer (35 papers), Pancreatic function and diabetes (35 papers), Diabetes Treatment and Management (33 papers) and Bariatric Surgery and Outcomes (25 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (8.3k citations), Epidemiology (9.6k citations), Physiology (5.9k citations), Hepatology (1.4k citations) and Cell Biology (2.4k citations). Amalia Gastaldelli has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Ele Ferrannini, Ralph A. DeFronzo, Melania Gaggini, Kenneth Cusi, Andrea Mari, Elisabetta Bugianesi, Robert R. Wolfe, Labros S. Sidossis, E. Buzzigoli and Stefania Camastra. Their work appears in journals such as Diabetes, The Journal of Clinical Endocrinology & Metabolism, Diabetologia, Journal of Hepatology and American Journal of Physiology-Endocrinology and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.